Using Medication Reconciliation To Streamline Optimal Medication Selection

Abstract

The average bio-behavioral medication takes four to six weeks to take effect and if non-compatible with the patient, they are delayed another four to six weeks for the second medication trial to take effect, and another for each failed medication. This delay in effect is crucial for bio-behavioral medications to be optimally selected the first time around.Purpose The purpose of this Evidence Based Practice study is to assess if using the Medication Reconciliation (MR) form as a guide can increase the provider confidence level in optimally selecting the initial medication for a new bio- behavioral diagnosis. Methods Custom MR forms were completed for eligible patients. After 6 weeks of implementation, providers were asked to fill out a Likert Scale survey on their confidence levels of selecting the optimal drug of choice for a new diagnosis. Results The mean of the confidence level prior to implementation was a 3.5/5 scale, whereas post implementation was a 4.5/5 scale (Graph 1). There was a 20% increase in confidence level after utilizing the MR forms. Discussion The MR form was found to increase confidence level in selecting the optimal drug as well as help in other areas for this practice, such as categorize patient’s eligibility for Transcranial magnetic stimulation (TMS) and confirm patient registration with Prescription Drug Monitoring Programs (PDMP). Some limitations to this project were the small sample size, n=2 and could only be done with patients who remembered their medications and history. The MR form can serve as a key for the connection between the patient and APRN and help with medication adherence and prevent medication errors in outpatient settings. Next steps for this project would be transcribing it into their EMR system and assessing which patients it would be most effective for.